Pharmaceutical Commerce

Integrating DTP Models Into Modern Drug Commercialization Plans

Jordan Armstrong, VP of Business Development at AssistRX, explains how companies can tailor direct-to-patient strategies into their commercialization plans. At this year’s Access USA conference, ...
Opinion
Las Vegas SunOpinion

n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines

Lo, Ph.D., Professor at the MIT Sloan School of Management and a member of n-Lorem’s board of directors, have published a commentary in Nature Biotechnology that proposes more economically feasible ...
Becker's Hospital Review

Sarepta plans to sell $225M of stock to support clinical trials, drug commercialization

Following the FDA’s approval Monday of its muscular dystrophy drug, Cambridge, Mass.-based Sarepta Therapeutics plans to sell up to $255 million of stock and use the proceeds to fund clinical trials, ...
Fierce Healthcare

Eversana, Waltz Health to merge and form combined pharmaceutical pricing platform

Health tech company Waltz Health will merge with Eversana with the goal of shaking up access to prescription drugs. The deal will bring together Waltz's proprietary drug marketplaces and ...
Seeking Alpha

NeuroOne plans 2026 drug delivery commercialization as Q4 product revenue jumps 907%

Rosa explained the company will issue financial guidance for fiscal 2026 after receiving final projections from Zimmer Biomet. "We plan on providing financial guidance for fiscal year 2026 once we ...

PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application

FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization PreparationsCompany On Track to Initiate NDA Submission by the ...
KXAN

EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access

Combined company offers next-generation commercialization model that directly connects life sciences to payers and patients to accelerate access, improve affordability and transform drug value across ...
Business Wire

Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced a discovery ...
WRBL

Nurix Therapeutics Expands Its Board of Directors with the Addition of Drug Commercialization Expert Anil Kapur

SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat ...
Morningstar

Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug

Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug NeuroSense's Groundbreaking ALS Combination Therapy PrimeC Advances Towards commercialization in ...

Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and ...